arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

Lite Strategy, Inc.

LITS
$0.97 ▼ -0.11 (-10.41%) at close
Healthcare ·Pharmaceutical Preparations ·USPharmaceutical Preparations
25 Visible periods
29 Metrics
Peer-ranked Benchmarks
Price Chart
9
Health
Poor
Bearish
auto_awesome

Analytical Summary

Lite Strategy, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $33.5M
Dividend Yield —
Revenue Growth None
Op. Margin None
ROIC -160.0% ↘
FCF / Share $-0.26 ↗
Trailing P/E —
Price / Book 0.8x
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Nov 5, 2026.

25-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$0.00
↓ -100.0% —
Net Income Profit after all expenses
$-71.15M
↓ -346.2% —
Operating Margin Operating profit as % of sales
22.3%
↑ +129.6% —
FCF / Share Free cash flow per share
$-0.26
↑ +91.6% —
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↓
3
Cash Quality ↓
25

Dividend History

Dividend / share · sourced from SEC filings
$1.75 Latest / share

bar_chart Data from SEC EDGAR XBRL filings

Synced 5 days ago 25 years · 73 quarters